R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
Title:
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
Author:
Kühnl, Andrea Peckitt, Clare Patel, Bijal Ardeshna, Kirit M. Macheta, Marian P. Radford, John Johnson, Rod Paneesha, Shankaranarayana Barton, Sarah Chau, Ian Begum, Ruwaida Valeri, Nicola Wotherspoon, Andrew Du, Yong Zerizer, Imene Cunningham, David